Vanguard Asset Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
Vanguard Asset Management's TYRA Position: Q3 2026 in Review
Vanguard Asset Management increased its Tyra Biosciences (TYRA) stake by 39% in Q3 2026, buying an estimated $165K and bringing the position to 21,474 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.
Vanguard Asset Management first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $494K in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- Vanguard Asset Management held 21,474 shares of Tyra Biosciences worth $470K as of Q3 2026.
- Vanguard Asset Management bought 5,995 Tyra Biosciences shares in Q3 2026, an estimated $165K.
- Tyra Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2211 holding.
- Vanguard Asset Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Tyra Biosciences position peaked at $494K in Q2 2026.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.